[email protected]

国际临床研究杂志

International Journal of Clinical Research

您当前位置:首页 > 精选文章

International Journal of Clinical Research. 2022; 6: (9) ; 10.12208/j.ijcr.20220446 .

Application of various blood purification equipment in patients with hyperlipidemic severe acute pancreatitis
多种血液净化装备在高脂血症性重症急性胰腺炎患者中的应用探讨

作者: 霍小艳 *

榆林市第二医院重症医学科 陕西榆林

*通讯作者: 霍小艳,单位:榆林市第二医院重症医学科 陕西榆林;

引用本文: 霍小艳 多种血液净化装备在高脂血症性重症急性胰腺炎患者中的应用探讨[J]. 国际临床研究杂志, 2022; 6: (9) : 97-99.
Published: 2022/11/29 16:22:56

摘要

目的 分析多种血液净化装备在高脂血症性重症急性胰腺炎患者中的应用效果。方法 回顾性分析100例高脂血症性重症急性胰腺炎患者临床资料,治疗时间为2019年1月-2022年4月,随机分两组,A组采用血浆置换结合持续性血液滤过治疗,B组采用持续性血液滤过治疗,对比A组及B组的治疗结局。结果 A组患者症状改善时间远远短于B组,有统计学意义P<0.05。治疗前,A组患者临床指标接近于B组(P>0.05);治疗3天后,A组与B组患者APACHEII评分、IL-6、CRP、血清TG水平均低于治疗前,且A组患者更低,有统计学意义(P<0.05)。结论 多种血液净化装备在高脂血症性重症急性胰腺炎患者中的应用效果更明显,值得广泛利用。

关键词: 高脂血症性重症急性胰腺炎;持续性血液滤过;炎性指标

Abstract

Objective To analyze the application effect of various blood purification equipment in patients with hyperlipidemic severe acute pancreatitis.
Methods the clinical data of 100 patients with hyperlipidemic severe acute pancreatitis were analyzed retrospectively. The treatment period was from January 2019 to April 2022. They were randomly divided into two groups. Group A was treated with plasma exchange combined with continuous hemofiltration, and Group B was treated with continuous hemofiltration. The treatment outcomes of Group A and Group B were compared.
Results the improvement time of symptoms in group A was significantly shorter than that in group B (P < 0.05). Before treatment, the clinical indexes of group A were close to those of group B (P > 0.05); After 3 days of treatment, Apache Ⅱ score, IL-6, CRP and serum TG levels of patients in group A and B were lower than those before treatment, and those in group A were lower (P < 0.05).
Conclusion   the application of various blood purification equipment in patients with hyperlipidemic severe acute pancreatitis is more effective and worthy of extensive use.

Key words: hyperlipidemic severe acute pancreatitis; Continuous hemofiltration; Inflammatory index

参考文献 References

[1] 韩冰,吴志雄,宋晓华.血液净化在老年重症急性胰腺炎患者中的应用[J].老年医学与保健,2022,28(01):7-11.

[2] 赵伟鹏.生长抑素联合血液净化对急性胰腺炎患者临床症状改善及血流动力学的影响[J].辽宁医学杂志,2021,35(06):55-57.

[3] 韩宁,熊学梅.持续性血液净化与生长抑素对重症急性胰腺炎患者的临床效果及血流动力学的影响[J].医学理论与实践,2021,34(21):3734-3736.

[4] 李彦磊,李畅,岳志城.乌司他丁联合连续血液净化对急性重症胰腺炎患者T淋巴细胞亚群及炎症指标的影响[J].现代诊断与治疗,2021,32(20):3237-3238.

[5] 房健健,焦清海,王健,张雪梅,田英平.血浆置换联合血液净化治疗高脂血症性重症急性胰腺炎患者的疗效分析[J].河北医药,2021,43(19):2986-2988.

[6] 王光江.连续性血液净化对重症胰腺炎患者肾素-血管紧张素-醛固酮系统及炎症因子水平的影响[J].国际移植与血液净化杂志,2021,19(05):16-18.

[7] 杨明,杨琳,樊哲,张颖毅,潘吉勇.杂合式血液净化序贯联合参麦注射液治疗急性重症胰腺炎患者临床观察[J].中国实用医药,2021,16(25):140-142.

[8] 罗君.连续血液净化在急性重症胰腺炎合并脓毒血症患者中辅助治疗效果[J].岭南急诊医学杂志,2021,26(04): 393-394.

[9] 李在楠.联合血液净化治疗对重症急性胰腺炎患者的临床疗效及炎症因子影响分析[J].中国实用医药,2021,16(20):165-167.

[10] 吕春婷,付黎明,岳磊.杂合式血液净化在重症急性胰腺炎并发MODS患者中的应用[J].实用医药杂志,2021,38(07):602-604.

[11] 崔娟,王博,徐雯,施永涛,陈俊,郭剑波.联合血液净化治疗在重症急性胰腺炎患者中的应用[J].中国当代医药,2021,28(19):72-74.

[12] 廖家贤.重症急性胰腺炎患者应用连续性血液净化治疗对其免疫功能及生化指标的影响[J].吉林医学,2021,42(04):956-957.

[13] 乔妍.血液灌流联合连续性血液净化治疗对重症急性胰腺炎患者血清炎症因子水平及并发症的影响[J].实用医技杂志,2021,28(04):503-505.

[14] 陈杰明,王金莉,穆恩.重症急性胰腺炎全身炎症反应综合征患者治疗中血液灌流联合持续性血液净化的应用研究[J].中国社区医师,2021,37(07):18-19.

[15] 石瑜珍,刘淑芳,林胜阳.多种血液净化装备在高脂血症性重症急性胰腺炎患者中的应用效果[J].中国医疗器械信息,2017,23(16):106-107.